Meanwhile https://www.covid19treatmentguidelines.nih.gov/therapies/imm...
"Further studies are needed to establish whether the anti-inflammatory effects of fluvoxamine observed in nonclinical studies also occur in humans beings and are clinically relevant in the setting of COVID-19."